These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21538846)

  • 1. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
    Shimizu M; Shirakami Y; Moriwaki H
    Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
    Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
    Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
    Suganuma M; Saha A; Fujiki H
    Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.
    Larsen CA; Dashwood RH; Bisson WH
    Pharmacol Res; 2010 Dec; 62(6):457-64. PubMed ID: 20691268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
    Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
    Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Fay JR; Steele VE; Lubet RA; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):657-66. PubMed ID: 8824370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.
    Kazi A; Smith DM; Daniel K; Zhong S; Gupta P; Bosley ME; Dou QP
    In Vivo; 2002; 16(6):397-403. PubMed ID: 12494882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
    Dong Z; Ma W; Huang C; Yang CS
    Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
    Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.